My Recruiting Blog

A new state-of-the-art medical research and development facility will support hundreds of oncology jobs. Visit http://azjobs.cancercenter.com/jobs for more openings.

EMD Serono recently opened a new research center in Billerica, a nearby suburb of Boston. The new facility will be used to develop and discover innovative treatments in oncology, neurodegenerative diseases, and infertility.

The research center is expected to create about 100 new jobs and attract a total of 200 scientists with experience in cancer biology, cancer immunotherapy, oncogene signaling, medicinal chemistry, molecular modeling, protein engineering, therapeutic antibodies, and manufacturing cell lines.

"This research expansion represents EMD Serono's clear purpose of scientific and medical innovation, and solidifies the company's presence in Massachusetts as a leading, global organization in the life sciences industry," Fereydoun Firouz, president and CEO of EMD Serono, said in a statement. "We are focused on retaining and attracting the best scientists to develop therapies that provide value and breakthrough solutions to people living with serious medical conditions such as fertility disorders, cancer and neurodegenerative diseases."

The new $65 million facility will measure about 140,000 square feet, including chemistry and screening labs, biology and cell culture labs, general lab support space, offices and conference rooms, and mechanical space. EMD Serono is currently looking to earn a LEED Gold certification for the facility.

The location of EMD Serono's new facility will allow the company to maintain its existing relationships and partnerships with many area institutions, research organizations, hospitals, and healthcare institutions.

"The research institute in Billerica will bring together EMD Serono scientists, researchers and stakeholders in our research network which allows for greater synergy, collaboration and development of innovative science,"  Dr. Bernhard Kirschbaum, executive vice president of research and development for Merck Serono, said in a statement.

"In addition, the establishment of EMD Serono's research facility center of excellence in Massachusetts provides an opportunity to tap into world-renowned academic and research institutions that are located in close proximity to our new facility in order to further collaborate with a common objective to drive science forward," he added.

EMD Serono and Merck Serono are both affiliates of pharmaceutical and chemical company Merck KGaA. The company operates three other research centers in Germany, Switzerland, and China.

Labels: Oncology jobs